Article ID Journal Published Year Pages File Type
5590872 Multiple Sclerosis and Related Disorders 2017 7 Pages PDF
Abstract
Modified premedication scheme consisting of 1 g/day of IV methylprednisolone throughout all 5 days of alemtuzumab treatment may reduce overall IARs. Intravenous administration of antipyretics may work better than oral administration.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Genetics
Authors
, , , , , ,